As of 2025-07-04, the Relative Valuation of BioPharma Credit PLC (BPCR.L) is 1.15 USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.88 USD, the upside of BioPharma Credit PLC based on Relative Valuation is 31.0%.
The range of the Relative Valuation is 0.88 - 1.70 USD.
| Range | Selected | |
| Trailing P/E multiples | 9.5x - 15.7x | 11.8x |
| Forward P/E multiples | 9.6x - 15.9x | 11.1x |
| Fair Price | 0.88 - 1.70 | 1.15 |
| Upside | 0.3% - 93.7% | 31.0% |
| Date | P/E |
| 2025-07-03 | 8.17 |
| 2025-07-02 | 8.13 |
| 2025-07-01 | 8.17 |
| 2025-06-30 | 8.17 |
| 2025-06-27 | 8.13 |
| 2025-06-26 | 8.13 |
| 2025-06-25 | 8.32 |
| 2025-06-24 | 8.25 |
| 2025-06-23 | 8.28 |
| 2025-06-20 | 8.34 |
| 2025-06-19 | 8.32 |
| 2025-06-18 | 8.34 |
| 2025-06-17 | 8.41 |
| 2025-06-16 | 8.37 |
| 2025-06-13 | 8.41 |
| 2025-06-12 | 8.32 |
| 2025-06-11 | 8.21 |
| 2025-06-10 | 8.12 |
| 2025-06-09 | 8.13 |
| 2025-06-06 | 8.08 |
| 2025-06-05 | 8.13 |
| 2025-06-04 | 8.10 |
| 2025-06-03 | 8.13 |
| 2025-06-02 | 8.13 |
| 2025-05-30 | 8.13 |
| 2025-05-29 | 8.13 |
| 2025-05-28 | 8.13 |
| 2025-05-27 | 8.15 |
| 2025-05-23 | 8.13 |
| 2025-05-22 | 8.13 |
| 2025-05-21 | 7.99 |
| 2025-05-20 | 8.21 |
| 2025-05-19 | 8.17 |
| 2025-05-16 | 8.04 |
| 2025-05-15 | 8.04 |
| 2025-05-14 | 8.17 |
| 2025-05-13 | 8.21 |
| 2025-05-12 | 8.15 |
| 2025-05-09 | 8.21 |
| 2025-05-08 | 8.15 |
| 2025-05-07 | 8.08 |
| 2025-05-06 | 8.02 |
| 2025-05-02 | 7.95 |
| 2025-05-01 | 7.91 |
| 2025-04-30 | 7.89 |
| 2025-04-29 | 7.95 |
| 2025-04-28 | 7.91 |
| 2025-04-25 | 7.89 |
| 2025-04-24 | 7.93 |
| 2025-04-23 | 8.02 |